BNTX — BioNTech SE
5 mentions in the last 24 hours · 0.02% of all mentions
Why people talked about BNTX (2026-11-03)
- BioNTech reported Q3 earnings that exceeded estimates for both revenue and adjusted EPS.
- The company raised its full-year revenue guidance to a range of €1.70B–€1.90B.
- Cancer pipeline progress contributed to positive market sentiment despite a decline in COVID-related revenue.
| Bluesky | 5 | community |